ISSN 2051-8315
Psychopathology Review
      Lost your password ?
 Volume 1, Issue 1, 157-168, 2014
Abstract  E-mail Abstract   Article Purchase as PDF 
Return to Issue List 
D-Cycloserine Augmented Treatment of Anxiety Disorders in Children and Adolescents: A Review of Preliminary Research

  Simon Byrne - Centre for Emotional Health, Department of Psychology, Macquarie University.
  Lara Farrell - School of Applied Psychology, Griffith Health Institute, Griffith University.
  Eric Storch - Department of Paediatrics, Rothman Centre for Neuropsychiatry, University of South Florida.
  Ronald Rapee - Centre for Emotional Health, Department of Psychology, Macquarie University.

Volume 1, Issue 1, 2014, Pages 157-168

This paper reviews evidence for using the "cognitive enhancer" D-Cycloserine (DCS) to treat anxious young people. Adult studies indicate DCS consolidates fear extinction learning into memory during exposure therapy, thereby increasing the speed of remission. This paper examines basic research indicating both fear extinction and DCS may work differently in younger animals compared to adults. It reviews trials using DCS to enhance treatment of obsessive compulsive disorder in youths. Given there is often ambivalence about using medication to treat young people, this paper also reviews current research examining parental attitudes to DCS. It considers specific challenges facing DCS research, particularly with regard to maintaining experimental control and managing negative perceptions associated with using medication. Finally, this paper considers current research underway, particularly with regard to using DCS to treat young people with specific phobias. Overall, findings indicate that DCS shows promise for enhancing the treatment of anxiety in young people, but further investigation is needed to determine whether it provides significant benefits over and above current therapies.

Table of Contents
D-Cycloserine as a Cognitive Enhancer for Exposure Therapy
What Can Be Learnt From Adult D-Cycloserine Studies
Will D-Cycloserine Work in Children? Evidence from Fear Extinction in Younger Animals
D-Cycloserine Augmentation for Childhood Obsessive Compulsive Disorder
Will Parents Allow their Children to Take D-Cycloserine?
Issues when Conducting D-Cycloserine Research in Children: Maintaining Control Whilst Managing Perception
Current Trends and Future Directions

Correspondence to
Simon P. Byrne, Centre for Emotional Health, Department of Psychology, Faculty of Human Sciences, Building C3A, Macquarie University, North Ryde, 2109, Australia.

Cognitive Enhancer, D-Cycloserine, Exposure Therapy, Anxiety, Specific Phobia, Obsessive Compulsive Disorder

Received 16 Sep 2013; Revised 16 Dec 2013; Accepted 12 Jan 2014; In Press 28 Jul 2014

Bookmark and Share

Related articles by AUTHORS
Intensive Cognitive-Behavioural Treatment for Specific Phobia in Children and Adolescents

Intensive Cognitive Behavioural Treatment for Obsessive Compulsive Disorder in Children and Adolescents

Related articles by KEYWORDS
Intensive Cognitive-Behavioural Treatment for Specific Phobia in Children and Adolescents
(specific phobia)

Brief Treatment of Child Social Anxiety Disorder
(specific phobia)

Anxiety in Preadolescent Children: What Happens If We Don't Treat It, and What Happens If We Do?

Parent-Child Interactions and Adolescent Anxiety: A Systematic Review

Computer-based Treatment Programs for Youth Anxiety: A Systematic Review

DSM-5 and the Assessment of Childhood Anxiety Disorders: Meaningful Progress, New Problems, or Persistent Diagnostic Quagmires?

A Cognitive-Neuropsychological Account of Treatment Action in Anxiety: Can We Augment Clinical Efficacy?

Internalizing psychopathology across the life course: from genes and environment to gene-environment interaction

© Copyright 2009-2015 Textrum Ltd . All rights reserved. Published in the UK. Advertise | Privacy Policy | Terms of Use